|
| 37439804 | Accuracy of VO<sub>2</sub> estimation according to the widely used Krakau formula for the prediction of cardiac output. | Herz | 2024 |
| 38060068 | RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizations. | Infection | 2024 |
| 36166067 | Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys. | Clin Res Cardiol | 2023 |
| 37670404 | Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future? | Eur Heart J | 2023 |
| 37649316 | Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. | ESC Heart Fail | 2023 |
| 37688355 | Prevalence of anti-beta-1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcome. | ESC Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 37973338 | Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. | Lancet Glob Health | 2023 |
| 35648270 | Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. | Clin Res Cardiol | 2023 |
| 37191704 | Global Variations in Heart Failure Etiology, Management, and Outcomes. | JAMA | 2023 |
| 36974770 | Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. | Eur J Heart Fail | 2023 |
| 37100832 | Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients. | Sci Rep | 2023 |
| 36718715 | Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial. | JACC Heart Fail | 2023 |
| 36732921 | Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction. | ESC Heart Fail | 2023 |
| 36633452 | Post-COVID Syndrome. | Dtsch Arztebl Int | 2023 |
| 36001989 | The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial. | Eur Heart J Qual Care Clin Outcomes | 2023 |
| 36196060 | Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. | Eur J Heart Fail | 2023 |
| 34516969 | A global perspective of racial differences and outcomes in patients presenting with acute heart failure. | Am Heart J | 2022 |
| 35383832 | Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35429091 | Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). | Eur J Heart Fail | 2022 |
| 35393622 | Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. | Eur Heart J | 2022 |
| 35184572 | Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials. | Circ Heart Fail | 2022 |
| 35067564 | Heart failure classification in clinical practice: time to redefine? | Chin Med J (Engl) | 2022 |
| 34913270 | Sex-specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure. | ESC Heart Fail | 2022 |
| 35064730 | Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. | Eur J Heart Fail | 2022 |
| 34910136 | Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. | Eur Heart J | 2022 |
| 34738340 | Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring. | ESC Heart Fail | 2022 |
| 34332057 | Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. | J Card Fail | 2021 |
| 37039762 | Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. | Eur J Prev Cardiol | 2021 |
| 33839078 | Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. | JACC Heart Fail | 2021 |
| 33932134 | Impact of diastolic dysfunction on outcome in heart failure patients with mid-range or reduced ejection fraction. | ESC Heart Fail | 2021 |
| 33687526 | [Medical specialist training internal medicine : Case-related learning using the new Model-Speciality-Training-Regulations]. | Internist (Berl) | 2021 |
| 33496311 | Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure-the COGNITION.MATTERS-HF cohort study. | Eur Heart J | 2021 |
| 33496189 | Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes. | J Am Heart Assoc | 2021 |
| 34498435 | Echocardiographic risk factors of left ventricular thrombus in patients with acute anterior myocardial infarction. | ESC Heart Fail | 2021 |
| 34638159 | [Seroprevalence of COVID-19 and Psychosocial Effects in the General Population: Results of the STAAB-COVID-One Program]. | Gesundheitswesen | 2021 |
| 34518567 | Functional versus morphological assessment of vascular age in patients with coronary heart disease. | Sci Rep | 2021 |
| 34514815 | Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials. | J Am Heart Assoc | 2021 |
| 34107289 | Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials. | Am Heart J | 2021 |
| 33934554 | Adaptive anti-myocardial immune response following hospitalization for acute heart failure. | ESC Heart Fail | 2021 |
| 30957867 | Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial. | Eur Heart J | 2020 |
| 32087174 | Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. | Lancet Glob Health | 2020 |
| 31886953 | Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis. | Eur J Heart Fail | 2020 |
| 31913404 | Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure. | JAMA Cardiol | 2020 |
| 33027194 | Therapeutic Monitoring of Direct Oral Anticoagulants-Back to the Future? | J Cardiovasc Pharmacol | 2020 |
| 33074507 | Terminale Herzinsuffizienz: Neue Ansätze der ambulanten Therapie : Kardiologie -- Autoren: G. Güder, C. Angermann, G. Ertl. | MMW Fortschr Med | 2020 |
| 33392222 | COVID-19 Induced Acute Respiratory Distress Syndrome-A Multicenter Observational Study. | Front Med (Lausanne) | 2020 |
| 33351181 | Command and control in hospitals during SARS-CoV-2 pandemic: The windmill model of disaster response. | J Emerg Manag | 2020 |
| 32605581 | Hospital preparedness for mass critical care during SARS-CoV-2 pandemic. | Crit Care | 2020 |
| 32710857 | Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. | Lancet Glob Health | 2020 |